TickerFacts.

Vitaspring Biomedical Co. Ltd. (VSBC): Cost of Revenue

Annual figures by period end, from SEC filings.

$0
Year ended 2026-01-31
$3.55M2019-01-31: $3.5K2020-01-31: $13.4K2021-01-31: $136.0K2022-01-31: $3.55M2023-01-31: $3.33M2024-01-31: $02025-01-31: $02026-01-31: $0$0
2019-01-31 Cost of Revenue (USD) 2026-01-31
Period endedCost of RevenueChange YoYSource filing
2026-01-31$0n/a2026-06-17, From 2025-02-01
2025-01-31$0n/a2026-06-17, From 2024-02-01
2024-01-31$0-100.0%2026-03-12, From 2023-02-01
2023-01-31$3.33M-6.0%2026-03-12, From 2022-02-01
2022-01-31$3.55Mn/m2025-12-01, From 2021-02-01
2021-01-31$136.0K+911.5%2022-05-03, From 2020-02-01
2020-01-31$13.4K+288.4%2021-04-14, From 2019-02-01
2019-01-31$3.5Kn/a2020-06-09, From 2018-02-04

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0n/a
Incyte Corp (INCY)2025-12-31$372.13M+19.2%
Icon PLC (ICLR)2024-12-31$5.85B+2.2%
MaxCyte, Inc. (MXCT)2025-12-31$6.22M-12.4%
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$40.1K-12.0%
iSpecimen Inc. (ISPC)2025-12-31$1.90M-64.1%
OneMedNet Corp (ONMD)2025-12-31$1.86M+101.5%
Weed, Inc. (BUDZ)2025-12-31$0n/a

Compare VSBC, INCY, ICLR, MXCT side by side · Screen every company in Services-Commercial Physical & Biological Research ↗